logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
C

Claudine Isaacs

hackensack university medical center

97H-index
750Paper Count
3.7WCitation Count
Published Papers 232
Publication Date
logo
Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over five-year follow-up
errJNCI Cancer Spectrum
IF4.1
err2026-03-17
err0
errOAAI
errKathleen Van Dyk, PhD; Wanting Zhai, M.S; Tim A Ahles, PhD; James C Root, PhD; Jaeil Ahn, PhD; Ashley L Artese, PhD; Traci N Bethea, PhD; Harvey J Cohen, MD; Martine Extermann, MD; Deena Graham, MD; Claudine Isaacs, MD; Heather S L Jim, PhD; Brenna C McDonald, PsyD; Zev M Nakamura, MD; Sunita K Patel, PhD; Kelly E Rentscher, PhD; Andrew J Saykin, PsyD; Brent J Small, PhD; Danielle B Tometich, PhD; Xingtao Zhou, MS; Judith E Carroll, PhD; Jeanne S Mandelblatt, MPH, MD
errShare
errSave
BDNF genotype and cognition in older adults with breast cancer and healthy controls in the Thinking and Living with Cancer Study
errJournal of Geriatric Oncology
IF2.7
err2025-12-10
err0
PREAI
errZev M. Nakamura; Brent J. Small; Xingtao Zhou; Jaeil Ahn; Tim A. Ahles; Ashley L. Artese; Harvey Jay Cohen; Martine Extermann; Deena Graham; Claudine Isaacs; Heather S.L. Jim; Brenna C. McDonald; Kelly Nudelman; Sunita K. Patel; Kelly E. Rentscher; James C. Root; Andrew J. Saykin; Kathleen Van Dyk; Claire E. Wegel; Jeanne S. Mandelblatt
errShare
errSave
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors
errNature Communications
IF15.7
err2025-12-09
err0
errOAAI
errMark Jesus M. Magbanua; Nayelis A. Manon; Denise M. Wolf; Samuel Rivero-Hinojosa; Ziad Ahmed; Rosalyn W. Sayaman; Antony Tin; Derrick Renner; Ekaterina Kalashnikova; Lamorna Brown-Swigart; Gillian L. Hirst; Christina Yau; Wen Li; Claudine Isaacs; Rebecca A. Shatsky; Amy S. Clark; Alexandra Zimmer; Amy L. Delson; Angel Rodriguez; Minetta C. Liu; Paula R. Pohlmann; Laura J. Esserman; Hope S. Rugo; Angela DeMichele; Laura van ‘t Veer
errShare
errSave
Palbociclib with adjuvant endocrine therapy in early breast cancer: five-year follow up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)
errAnnals of Oncology
IF65.4
err2025-10-17
err0
errOAAI
errE.L. Mayer; D. Hlauschek; M. Gnant; P.J. O'Brien; M. Bellet-Ezquerra; M.P. Goetz; M. Ruiz-Borrego; A. Chan; K. Clifton; D. Egle; D. Lake; P. Cabrera; T. Mamounas; G. Pristauz-Telsnigg; Z. Dayao; M. Gil Gil; D. Cameron; T. Traina; P.G. Morris; D. Sabanathan; G. Rinnerthaler; J. Meisel; A. Prat; A.C. Wolff; L-M. Tseng; C. Isaacs; C.F. Singer; G. Rubovszky; T. Foukakis; J. Jassem; E.P. Winer; M. Vetter; J. Federmann; O. Metzger; C. Schurmans; E. Gauthier; D.R. Lu; C. Fesl; A. Dueck; A. DeMichele
errShare
errSave
ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial
errAnnals of Surgical Oncology
IF3.5
err2025-08-29
err0
PREAI
errJulie Van Hassel; Katrina Dimitroff; Christina Yau; Rita Mukhtar; Judy C. Boughey; Velle Ladores; Marissa M. Howard-McNatt; Nora Jaskowiak; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Laura van’t Veer; Hope Rugo; Laura J. Esserman; Rebecca Shatsky; Claudine Isaacs; Henry Kuerer; Anne M. Wallace; Nicolas Prionas; Jennifer Tseng; Chantal R. Reyna; Neil Taunk; Susan Kesmodel; Marie C. Lee; Jana Fox; Mara A. Piltin; Julia Tchou; Cletus A. Arciero; Lauren M. Postlewait; Candice Sauder; Roshni Rao
errShare
errSave
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial
errAnnals of Surgical Oncology
IF3.5
err2025-08-23
err0
PREAI
errJulie Van Hassel; Katrina Dimitroff; Christina Yau; Rita Mukhtar; Judy C. Boughey; Velle Ladores; Marissa M. Howard-McNatt; Nora Jaskowiak; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Laura van’t Veer; Hope Rugo; Laura J. Esserman; Rebecca Shatsky; Claudine Isaacs; Henry Kuerer; Anne M. Wallace; Nicolas Prionas; Jennifer Tseng; Chantal R. Reyna; Neil Taunk; Susan Kesmodel; Marie C. Lee; Jana Fox; Mara A. Piltin; Julia Tchou; Cletus A. Arciero; Lauren M. Postlewait; Candice Sauder; Roshni Rao
errShare
errSave
ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial
errAnnals of Surgical Oncology
IF3.5
err2025-08-23
err0
PREAI
errRita A. Mukhtar; Katrina Dimitroff; Christina Yau; A. Jo Chien; Eileen P. Connolly; Marissa Howard-McNatt; Roshni Rao; Velle Ladores; Mehra Golshan; Candice A. Sauder; Kamran Ahmed; Rachael Lancaster; Jana Fox; Lily Gutnik; M. Catherine Lee; Julia Tchou; Nicolas Prionas; Cletus A. Arciero; Chantal Reyna; Henry Kuerer; Kayla Switalla; Neil Taunk; Todd M. Tuttle; Meena S. Moran; Lauren M. Postlewait; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Hope S. Rugo; Rebecca Shatsky; Claudine Isaacs; Laura J. Esserman; Laura van ‘t Veer; Judy C. Boughey
errShare
errSave
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial
errAnnals of Surgical Oncology
IF3.5
err2025-07-24
err0
errOAAI
errRita A. Mukhtar; Katrina Dimitroff; Christina Yau; A. Jo Chien; Eileen P. Connolly; Marissa Howard-McNatt; Roshni Rao; Velle Ladores; Mehra Golshan; Candice A. Sauder; Kamran Ahmed; Rachael Lancaster; Jana Fox; Lily Gutnik; M. Catherine Lee; Julia Tchou; Nicolas Prionas; Cletus A. Arciero; Chantal Reyna; Henry Kuerer; Kayla Switalla; Neil Taunk; Todd M. Tuttle; Meena S. Moran; Lauren M. Postlewait; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola Hylton; W. Fraser Symmans; Hope S. Rugo; Rebecca Shatsky; Claudine Isaacs; Laura J. Esserman; Laura van’t Veer; Judy C. Boughey
errShare
errSave
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial
errAnnals of Surgical Oncology
IF3.5
err2025-07-23
err0
errOAAI
errMandeep Kaur; Katrina Dimitroff; Judy C. Boughey; Laura J. Esserman; Christina Yau; Julia Tchou; Astrid Quirarte; Marie Catherine Lee; Marissa M. Howard-McNatt; Kayla Switalla; Henry Kuerer; Candice Sauder; Lauren M. Postlewait; Cletus Arciero; Roshni Rao; Anne Wallace; Chantal Reyna; Kamran Ahmed; Lily Gutnik; Neil Taunk; Jane Perlmutter; Angela DeMichele; Douglas Yee; Nola M. Hylton; W. Fraser Symmans; Hope S. Rugo; Rebecca A. Shatsky; Claudine Isaacs; Sonali Rudra; Paula Pohlmann; Cheryl Ewing; Jasmine Wong; Michael Alvarado; Nora Jaskowiak; Nicolas Prionas; Mehra Golshan; Mara A. Piltin; Olufunmilayo I. Olopade; Rita A. Mukhtar
errShare
errSave
Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial treated with immunotherapy, chemotherapy, or chemoimmunotherapy
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2025-04-23
err0
errOAAI
errToney, Nicole J.; Lynch, Megan T.; Lynce, Filipa; Mainor, Candace; Isaacs, Claudine; Schlom, Jeffrey; Donahue, Renee N.
errShare
errSave
Pathologic complete response (pCR) rates for patients with HRD/HER2L high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial
errANNALS OF ONCOLOGY
IF65.4
err2025-02-01
err2
PREAI
errHuppert, L. A.; Wolf, D.; Yau, C.; Brown-Swigart, L.; Hirst, G. L.; Isaacs, C.; Pusztai, L.; Pohlmann, P. R.; Demichele, A.; Shatsky, R.; Yee, D.; Thomas, A.; Nanda, R.; Perlmutter, J.; Heditsian, D.; Hylton, N.; Symmans, F.; van't Veer, L. J.; Esserman, L.; Rugo, H. S.
errShare
errSave
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2024-12-07
err1
PREAI
errPrasath, Vishnu; Boutrid, Hinda; Wesolowski, Robert; Abdel-Rasoul, Mahmoud; Timmers, Cynthia; Lustberg, Maryam; Layman, Rachel M.; Macrae, Erin; Mrozek, Ewa; Shapiro, Charles; Glover, Kristyn; Vater, Mark; Budd, G. Thomas; Harris, Lyndsay; Isaacs, Claudine; Dees, Claire; Perou, Charles M.; Johnson, Gary L.; Poklepovic, Andrew; Chen, Helen; Villalona-Calero, Miguel; Carson, William; Stover, Daniel G.; Ramaswamy, Bhuvaneswari
errShare
errSave
Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer
errBREAST CANCER RESEARCH AND TREATMENT
IF3
err2024-12-03
err0
errOAAI
errRugo, Hope S.; Campbell, Mike; Yau, Christina; Jo Chien, A.; Wallace, Anne M.; Isaacs, Claudine; Boughey, Judy C.; Han, Hyo S.; Buxton, Meredith; Clennell, Julia L.; Asare, Smita M.; Steeg, Katherine; Wilson, Amy; Singhrao, Ruby; Matthews, Jeffrey B.; Perlmutter, Jane; Fraser Symmans, W.; Hylton, Nola M.; Demichele, Angela M.; Yee, Douglas; Van't Veer, Laura J.; Berry, Donald A.; Esserman, Laura J.
errShare
errSave
Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA study
errNPJ BREAST CANCER
IF7.6
err2024-09-30
err0
errOAAI
errSchlam, Ilana; Smith, D. Max; Peer, Cody; Sissung, Tristan; Schmidt, Keith T.; Tan, Ming; Chitalia, Ami; Bishopric, Nanette H.; Steinberg, Seth; Choo-Wosoba, Hyoyoung; Napoli, Giulia; Gallagher, Christopher; Ashai, Nadia; Whitaker, Kristen; Mainor, Candace; Tiwari, Shruti; Swanson, Nicole; Malloy, Stacy; Isaacs, Claudine; Figg, William Douglas; Swain, Sandra M.
errShare
errSave
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
errNATURE MEDICINE
IF50
err2024-09-14
err1
PREAI
errKhoury, Katia; Meisel, Jane L.; Yau, Christina; Rugo, Hope S.; Nanda, Rita; Davidian, Marie; Tsiatis, Butch; Chien, A. Jo; Wallace, Anne M.; Arora, Mili; Rozenblit, Mariya; Hershman, Dawn L.; Zimmer, Alexandra; Clark, Amy S.; Beckwith, Heather; Elias, Anthony D.; Stringer-Reasor, Erica; Boughey, Judy C.; Nangia, Chaitali; Vaklavas, Christos; Omene, Coral; Albain, Kathy S.; Kalinsky, Kevin M.; Isaacs, Claudine; Tseng, Jennifer; Torres, Evanthia T. Roussos; Thomas, Brittani; Thomas, Alexandra; Sanford, Amy; Balassanian, Ronald; Ewing, Cheryl; Yeung, Kay; Sauder, Candice; Sanft, Tara; Pusztai, Lajos; Trivedi, Meghna S.; Outhaythip, Ashton; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Beedle, Carolyn; Perlmutter, Jane; Pohlmann, Paula; Shatsky, Rebecca A.; Demichele, Angela; Yee, Douglas; van't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.
errShare
errSave
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial
errNATURE MEDICINE
IF50
err2024-09-14
err4
PREAI
errShatsky, Rebecca A.; Trivedi, Meghna S.; Yau, Christina; Nanda, Rita; Rugo, Hope S.; Davidian, Marie; Tsiatis, Butch; Wallace, Anne M.; Chien, A. Jo; Stringer-Reasor, Erica; Boughey, Judy C.; Omene, Coral; Rozenblit, Mariya; Kalinsky, Kevin; Elias, Anthony D.; Vaklavas, Christos; Beckwith, Heather; Williams, Nicole; Arora, Mili; Nangia, Chaitali; Torres, Evanthia T. Roussos; Thomas, Brittani; Albain, Kathy S.; Clark, Amy S.; Falkson, Carla; Hershman, Dawn L.; Isaacs, Claudine; Thomas, Alexandra; Tseng, Jennifer; Sanford, Amy; Yeung, Kay; Boles, Sarah; Chen, Yunni Yi; Huppert, Laura; Jahan, Nusrat; Parker, Catherine; Giridhar, Karthik; Howard, Frederick M.; Blackwood, M. Michele; Sanft, Tara; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Heditsian, Diane; Lestage, Barbara; Perlmutter, Jane; Pohlmann, Paula; Demichele, Angela; Yee, Douglas; van 't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.
errShare
errSave
The impact of changes in tumor mutational landscape during neoadjuvant therapy on tumor-informed ctDNA testing in breast cancer patients
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errMagbanua, M.; Rivero-Hinojosa, S.; Sayaman, R.; Tin, T.; Kalashnikova, E.; Wolf, D.; Brown-Swigart, L.; Hirst, G.; Yau, C.; Isaacs, C.; Shatsky, R. A.; Delson, A.; Palsuledesai, C. C.; Rodriguez, A. A.; Liu, M. C.; Pohlmann, P. R.; Esserman, L.; Rugo, H. S.; DeMichele, A.; Van't Veer, L. J.
errShare
errSave
Physical activity and cognition: longitudinal findings from the Thinking and Living with Cancer Study
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2024-08-06
err0
PREAI
errArtese, Ashley L.; Zhou, Xingtao; Tometich, Danielle B.; Small, Brent J.; Ahles, Tim A.; Ahn, Jaeil; Bethea, Traci N.; Breen, Elizabeth C.; Cohen, Harvey J.; Extermann, Martine; Graham, Deena; Isaacs, Claudine; Jim, Heather S. L.; Mcdonald, Brenna C.; Nakamura, Zev M.; Patel, Sunita K.; Rentscher, Kelly E.; Root, James C.; Saykin, Andrew J.; Van Dyk, Kathleen; Zhai, Wanting; Carroll, Judith E.; Mandelblatt, Jeanne
errShare
errSave
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study (vol 15, 2691, 2024)
errNATURE COMMUNICATIONS
IF15.7
err2024-05-10
err0
errOAAI
errLynce, Filipa; Mainor, Candace; Donahue, Renee N.; Geng, Xue; Jones, Greg; Schlam, Ilana; Wang, Hongkun; Toney, Nicole J.; Jochems, Caroline; Schlom, Jeffrey; Zeck, Jay; Gallagher, Christopher; Nanda, Rita; Graham, Deena; Stringer-Reasor, Erica M.; Denduluri, Neelima; Collins, Julie; Chitalia, Ami; Tiwari, Shruti; Nunes, Raquel; Kaltman, Rebecca; Khoury, Katia; Gatti-Mays, Margaret; Tarantino, Paolo; Tolaney, Sara M.; Swain, Sandra M.; Pohlmann, Paula; Parsons, Heather A.; Isaacs, Claudine
errShare
errSave
Racial and Ethnic Differences in Clinical Outcomes among North American Patients with Hormone Receptor Positive, HER2-negative, Early Breast Cancer in the PALLAS Trial (AFT-05)
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errKantor, Olga; Fayanju, Oluwadamilola (Lola); Dueck, Amylou; Gnant, Michael; Burstein, Harold; Goetz, Matthew; Isaacs, Claudine; Shepherd, Lois; Hahn, Olwen; Anderson, Daniel; Miller, Kathy; Rugo, Hope; Traina, Tiffany; Dayao, Zoneddy; Clifton, Katherine; Winer, Eric; Wolff, Antonio; Wolmark, Norman; Lu, Dongrui; O'Brien, Patrick; Scovil, Sara; DeMichele, Angela; Mayer, Erica
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
W
Walter C. Willett
H-index: 313 · Papers: 2.7K
J
JoAnn E. Manson
H-index: 255 · Papers: 2.7K
H
Hermann Brenner
H-index: 202 · Papers: 3.3K
E
Elaine R. Mardis
H-index: 197 · Papers: 1.7K
B
Børge G. Nordestgaard
H-index: 192 · Papers: 1.8K
View more